High-Content Analysis-Based Sensitivity Prediction and Novel Therapeutics Screening for c-Met-Addicted Glioblastoma

por Oh, Jeong-Woo, Oh, Yun Jeong, Han, Suji, Her, Nam-Gu, Nam, Do-Hyun
Publicado 2021

The Protein Neddylation Inhibitor MLN4924 Suppresses Patient-Derived Glioblastoma Cells via Inhibition of ERK and AKT Signaling

por Han, Suji, Shin, Hyemi, Oh, Jeong-Woo, Oh, Yun Jeong, Her, Nam-Gu, Nam, Do-Hyun
Publicado 2019

Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells

por Her, Nam-Gu, Oh, Jeong-Woo, Oh, Yun Jeong, Han, Suji, Cho, Hee Jin, Lee, Yeri, Ryu, Gyu Ha, Nam, Do-Hyun
Publicado 2018

Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia

por Hong, Ji Hyung, Lee, Sung-Eun, Choi, Soo Young, Kim, Soo-Hyun, Jang, Eun-Jung, Bang, Ju-Hee, Park, Jin Eok, Jeon, Hye-Rim, Oh, Yun Jeong, Yi, Jeong-Eun, Jung, Hae Ok, Youn, Ho Joong, Kim, Dong-Wook
Publicado 2015